Activities of daily living · people with Alzheimer's disease
1 finding from 1 review
Progression to Alzheimer's disease Number of people progressing to AD · MCI
Vitamin E (capsules 2000 IU/day in two divided doses) showed no clear difference in progression to Alzheimer's disease Number of people progressing to AD compared with placebo (moderate certainty).
1 finding from 1 review
Change in ADAS‐Cog · MCI
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of participants experiencing any serious adverse events · MCI
1 finding from 1 review
Death Number of deaths over 36 months · MCI
Vitamin E (capsules 2000 IU/day in two divided doses) showed no clear difference in death Number of deaths over 36 months compared with placebo (moderate certainty).
1 finding from 1 review
Activities of daily living · MCI
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive function · patients with type 2 diabetes mellitus
1 finding from 1 review
Adverse events (Hypoglycaemia) · patients with type 2 diabetes mellitus
Intensive glycaemic control may leads to higher adverse events (Hypoglycaemia) compared with standard glycaemic control (low certainty).
1 finding from 1 review
All‐cause mortality · patients with type 2 diabetes mellitus
Intensive glycaemic control showed no clear difference in mortality compared with standard glycaemic control (moderate certainty).
Cognitive function · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of MCI · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of dementia · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (Hypoglycaemia) · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of MCI · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of dementia · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (Hypoglycaemia) · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Global cognitive function (defined as reduction of at least 3 points in MMSE) · patients with type 2 diabetes mellitus
Intensive glycaemic control showed no clear difference in global cognitive function (defined as reduction of at least 3 points… compared with standard glycaemic control (moderate certainty).
1 finding from 1 review
Cognitive function · patients with type 2 diabetes mellitus
1 finding from 1 review